Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $51,746 | 17 | 60.7% |
| Travel and Lodging | $23,377 | 26 | 27.4% |
| Honoraria | $4,000 | 2 | 4.7% |
| Food and Beverage | $3,946 | 65 | 4.6% |
| Unspecified | $1,831 | 2 | 2.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $250.00 | 1 | 0.3% |
| Education | $165.95 | 4 | 0.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $33,783 | 18 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $20,479 | 26 | $0 (2018) |
| Amgen Inc. | $11,036 | 17 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $6,215 | 7 | $0 (2019) |
| Allergan Inc. | $4,387 | 26 | $0 (2019) |
| Upsher-Smith Laboratories LLC | $4,325 | 5 | $0 (2018) |
| Pernix Therapeutics Holdings, Inc. | $2,332 | 3 | $0 (2017) |
| Lilly USA, LLC | $1,432 | 4 | $0 (2019) |
| Promius Pharma LLC | $1,140 | 4 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $70.55 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $104.32 | 2 | ABBVIE INC. ($59.46) |
| 2019 | $4,518 | 20 | Eli Lilly and Company ($1,699) |
| 2018 | $59,375 | 57 | Eli Lilly and Company ($32,085) |
| 2017 | $21,319 | 38 | Teva Pharmaceuticals USA, Inc. ($13,062) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/14/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $44.86 | General |
| Category: Neurology | ||||||
| 01/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $59.46 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2019 | Amgen Inc. | Aimovig (Biological) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Neuroscience | ||||||
| 07/22/2019 | Amgen Inc. | Aimovig (Biological) | — | In-kind items and services | $90.17 | Research |
| Study: Phase 3 Pivotal EMP (STRIVE) • Category: Neuroscience | ||||||
| 07/10/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2019 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $55.04 | General |
| 05/22/2019 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $35.43 | General |
| 05/19/2019 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $786.50 | General |
| 05/19/2019 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $780.00 | General |
| 05/19/2019 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $96.64 | General |
| 05/09/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $77.94 | General |
| Category: Neuroscience | ||||||
| 05/04/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2019 | Lilly USA, LLC | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 02/13/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Neuroscience | ||||||
| 02/08/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Education | In-kind items and services | $42.00 | General |
| 02/08/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Education | In-kind items and services | $42.00 | General |
| 02/08/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Education | In-kind items and services | $42.00 | General |
| 02/06/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/05/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: HYPERHYDROSIS | ||||||
| 01/31/2019 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $98.95 | General |
| 01/26/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $36.30 | General |
| Category: Neuroscience | ||||||
| 01/25/2019 | Promius Pharma LLC | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $58.75 | General |
| Category: Neurology | ||||||
| 12/21/2018 | Amgen Inc. | Aimovig (Biological) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Neuroscience | ||||||
| 12/14/2018 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 12/13/2018 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $7,600.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Phase 2 Chronic Migraine Prophylaxis | Amgen Inc. | $1,741 | 1 |
| Phase 3 Pivotal EMP (STRIVE) | Amgen Inc. | $90.17 | 1 |
About Dr. Bert Vargas, MD
Dr. Bert Vargas, MD is a Neurology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1205038627.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bert Vargas, MD has received a total of $85,316 in payments from pharmaceutical and medical device companies, with $104.32 received in 2024. These payments were reported across 117 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($51,746).
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Indianapolis, IN
- Active Since 06/05/2007
- Last Updated 10/31/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1205038627
Products in Payments
- TEV-48125 (Biological) $13,052
- Aimovig (Biological) $10,789
- MAYZENT (Drug) $6,059
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $4,325
- BOTOX (Biological) $3,894
- TREXIMET (Drug) $2,332
- Zembrace (Drug) $1,082
- BOTOX CHRONIC MIGRAINE (Drug) $321.46
- AIMOVIG (Biological) $135.73
- BOTOX COSMETIC (Biological) $126.00
- EMGALITY (Drug) $77.94
- ONZETRA Xsail (Drug) $59.61
- QULIPTA (Drug) $59.46
- ZEMBRACE SYMTOUCH (Drug) $58.75
- BOTOX THERAPEUTIC (Biological) $45.27
- Leqembi (Drug) $44.86
- AJOVY (Drug) $42.34
- OXTELLAR XR (Drug) $10.71
- COPAXONE (Drug) $10.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Indianapolis
Kristi George, Md, MD
Neurology — Payments: $318,483
Martin Farlow, Md, MD
Neurology — Payments: $291,677
Cassandra Curtis, Md, MD
Neurology — Payments: $231,041
Dr. Eric Siemers, M.d, M.D
Neurology — Payments: $128,503
Liana Apostolova, Md, MD
Neurology — Payments: $94,479
Jared Brosch, Md, MD
Neurology — Payments: $78,006